Summary
Electrophysiological techniques can be used to great effect to help determine the mechanism of action of a compound. However, many factors can compromise the resulting data and their analysis, such as the speed of solution exchange, expression of additional ion channel populations including other ligand-gated receptors and voltage-gated channels, compounds having multiple binding sites, and current desensitization and rundown. In this chapter, such problems and their solutions are discussed and illustrated using data from experiments involving the uncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist memantine. Memantine differs from many other NMDA receptor channel blockers in that it is well tolerated and does not cause psychotomimetic effects at therapeutic doses. Various electrophysiological parameters of NMDA-induced current blockade by memantine have been proposed to be important in determining therapeutic tolerability, potency, onset and offset kinetics, and voltage dependency. These were all measured using whole cell patch-clamp techniques using hippocampal neurons. Full results are shown here for memantine, and these are summarized and compared with those from similar experiments with other NMDA channel blockers. The interpretation of these results is discussed, as are theories concerning the tolerability of NMDA channel blockers, with the aim of illustrating how electrophysiological data can be used to form and support a physiological hypothesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Reisberg, B., R. Doody, A. Stoffler, F. Schmitt, S. Ferris, and H.J. Motrius (2003) Memantine in moderate-to-sexere Alzheimer’s disease. M. Engl. J. Med. 348, 1333–1341.
Tariot, P.N., M.R. Farlow, G.T. Grossberg, S.M. Graham, S. McDonald, and I. Gergel (2004) Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil – a randomized controlled trial. JAMA 291, 317–324.
Parsons, C.G., W. Danysz, and G. Quack (1999) Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data. Neuropharmacology 38, 735–767.
Danysz, W. and C.G. Parsons (2003) The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer’s disease: preclinical evidence. Int. J. Geriatr. Psychiatry 18, S23–S32.
Johnson, J.W. and S.E. Kotermanski (2006) Mechanism of action of memantine. Curr. Opin. Pharmacol. 6, 61–67.
Parsons, C.G., R. Gruner, J. Rozental, J. Millar, and D. Lodge (1993) Patch-clamp studies on the kinetics and selectivity of N-methyl-D-aspartate receptor antagonism by memantine (1-amino-3,5-dimethyladamantan). Neuropharmacology 32, 1337–1350.
Rogawski, M.A. (1993) Therapeutic potential of excitatory amino-acid antagonists – channel blockers and 2,3-benzodiazepines. Trends Pharmacol. Sci. 14, 325–331.
Blanpied, T.A., F.A. Boeckman, E. Aizenman, and J.W. Johnson (1997) Trapping channel block of NMDA-activated responses by amantadine and memantine. J. Neurophysiol. 77, 309–323.
Bresink, I., T.A. Benke, V.J. Collett, A.J. Seal, C.G. Parsons, J.M. Henley, and G.L. Collingridge (1996) Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br. J. Pharmacol. 119, 195–204.
Chen, H.S.V. and S.A. Lipton (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J. Physiol. (Lond.) 499, 27–46.
Parsons, C.G., S. Hartmann, and P. Spielmanns (1998) Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones. Neuropharmacology 37, 719–727.
Parsons, C.G., V.A. Panchenko, V.O. Pinchenko, A.Y. Tsyndrenko, and O.A. Krishtal (1996) Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur. J. Neurosci. 8, 446–454.
Parsons, C.G., G. Quack, I. Bresink, L. Baran, E. Przegalinski, W. Kostowski, P. Krzascik, S. Hartmann, and W. Danysz (1995) Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in-vitro with anticonvulsive and motor impairment activity in-vivo. Neuropharmacology 34, 1239–1258.
Sobolevsky, A. and S. Koshelev (1998) Two blocking sites of amino-adamantane derivatives in open N-methyl-d-aspartate channels. Biophys. J. 74, 1305–1319.
Sobolevsky, A.I., S.G. Koshelev, and B.I. Khodorov (1998) Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons. J. Physiol. (Lond.) 512, 47–60.
Clark, G.D., D.B. Clifford, and C.F. Zorumski (1990) The effect of agonist concentration, membrane voltage and calcium on N-methyl-D-aspartate receptor desensitization. Neuroscience 39, 787–797.
Grantyn, R. and H.D. Lux (1988) Similarity and mutual exclusion of NMDA-activated and proton-activated transient Na+-currents in rat tectal neurons. Neurosci. Lett. 89, 198–203.
Zilberter, Y., V. Uteshev, S. Sokolova, and B. Khodorov (1991) Desensitization of N-methyl-D-aspartate receptors in neurons dissociated from adult-rat hippocampus. Mol. Pharmacol. 40, 337–341.
Johnson, J.W. and P. Ascher (1987) Glycine potentiates the NMDA response in cultured mouse-brain neurons. Nature 325, 529–531.
Parsons, C.G., X.G. Zong, and H.D. Lux (1993) Whole-cell and single-channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br. J. Pharmacol. 109, 213–221.
Hashimoto, A. and T. Oka (1997) Free D-aspartate and D-serine in the mammalian brain and periphery. Prog. Neurobiol. 52, 325–353.
Hamill, O.P., A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391, 85–100.
Sigworth, F.J., H. Affolter, and E. Neher (1995) Design of the Epc-9, a computer-controlled patch-clamp amplifier. 2. Software. J. Neurosci. Methods 56, 203–215.
Albuquerque, E.X., E.F.R. Pereira, N.G. Castro, M. Alkondon, S. Reinhardt, H. Schroder, and A. Maelicke (1995) Nicotinic receptor function in the mammalian central-nervous-system, in Diversity of Interacting Receptors. New York Acad Sciences: New York, pp. 48–72.
Black, M., T. Lanthorn, D. Small, G. Mealing, V. Lam, and P. Morley (1996) Study of potency, kinetics of block and toxicity of NMDA receptor antagonists using fura-2. Eur. J. Pharmacol. 317, 377–381.
Rogawski, M.A., S.I. Yamaguchi, S.M. Jones, K.C. Rice, A. Thurkauf, and J.A. Monn (1991) Anticonvulsant activity of the low-affinity uncompetitive N-methyl-D-aspartate antagonist (+/-)-5-aminocarbonyl-10,11-dihydro-5h-dibenzo[a,D]cyclohepten-5, 10-imine (Adci) – comparison with the structural analogs dizocilpine (Mk-801) and carbamazepine. J. Pharmacol. and Exp. Ther. 259, 30–37.
Frankiewicz, T., B. Potier, Z.I. Bashir, G.L. Collingridge, and C.G. Parsons (1996) Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br. J. Pharmacol. 117, 689–697.
Chen, H.S.V., J.W. Pellegrini, S.K. Aggarwal, S.Z. Lei, S. Warach, F.E. Jensen, and S.A. Lipton (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine – therapeutic advantage against NMDA receptor-mediated neurotoxicity. Journal of Neuroscience 12, 4427–4436.
Clements, J.D., R.A.J. Lester, G. Tong, C.E. Jahr, and G.L. Westbrook (1992) The time course of glutamate in the synaptic cleft. Science 258, 1498–1501.
Nowak, L., P. Bregestovski, P. Ascher, A. Herbet, and A. Prochiantz (1984) Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307, 462–465.
Andine, P., M. Sandberg, R. Bagenholm, A. Lehmann, and H. Hagberg (1991) Intracellular and extracellular changes of amino-acids in the cerebral-cortex of the neonatal rat during hypoxic-ischemia. Brain Res. Dev. Brain Res. 64, 115–120.
Benveniste, H., J. Drejer, A. Schousboe, and N.H. Diemer (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral-ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369–1374.
Buisson, A., J. Callebert, E. Mathieu, M. Plotkine, and R.G. Boulu (1992) Striatal protection induced by lesioning the substantia-nigra of rats subjected to focal ischemia. J. Neurochem. 59, 1153–1157.
Globus, M.Y.T., R. Busto, E. Martinez, I. Valdes, W.D. Dietrich, and M.D. Ginsberg (1991) Comparative effect of transient global-ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric-acid in vulnerable and nonvulnerable brain-regions in the rat. J. Neurochem. 57, 470–478.
Globus, M.Y.T., M.D. Ginsberg, and R. Busto (1991) Excitotoxic index – a biochemical marker of selective vulnerability. Neurosci. Lett. 127, 39–42.
Mitani, A., Y. Andou, and K. Kataoka (1992) Selective vulnerability of hippocampal Ca1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil – brain microdialysis study. Neuroscience 48, 307–313.
Sobkowicz, H.M. and S.M. Slapnick (1992) Neuronal sprouting and synapse formation in response to injury in the mouse organ of corti in culture. Int. J. Dev. Neurosci 10, 545–566.
Sobkowicz, H.M., S.M. Slapnick, and B.K. August (1993) Presynaptic fibers of spiral neurons and reciprocal synapses in the organ of corti in culture. J. Neurocytol. 22, 979–993.
Davies, S.N., D. Martin, J.D. Millar, J.A. Aram, J. Church, and D. Lodge (1988) Differences in results from invivo and invitro studies on the use-dependency of N-methylaspartate antagonism by Mk-801 and other phencyclidine receptor ligands. Eur. J. Pharmacol. 145, 141–151.
Coan, E.J., A.J. Irving, and G.L. Collingridge (1989) Low-frequency activation of the NMDA receptor system can prevent the induction of Ltp. Neurosci. Lett. 105, 205–210.
Frankiewicz, T. and C.G. Parsons (1999) Memantine restores long term potentiation impaired by tonic N-methyl-D-aspartate (NMDA) receptor activation following reduction of Mg2+ in hippocampal slices. Neuropharmacology 38, 1253–1259.
Furukawa, Y., M. Okada, N. Akaike, T. Hayashi, and J. Nabekura (2000) Reduction of voltage-dependent magnesium block of N-methyl-D-aspartate receptor-mediated current by in vivo axonal injury. Neuroscience 96, 385–392.
Rogawski, M.A. and G.L. Wenk (2003) The neuropharmacological basis for the use of memantine in the treatment of Alzheimer’s disease. CNS Drug Rev. 9, 275–308.
Wang, L.Y. and J.F. Macdonald (1995) Modulation by magnesium of the affinity of NMDA receptors for glycine in murine hippocampal-neurons. J. Physiol. (Lond.) 486, 83–95.
Editor information
Rights and permissions
Copyright information
© 2007 Humana Press Inc.
About this protocol
Cite this protocol
Parsons, C.G., Gilling, K. (2007). Memantine as an Example of a Fast, Voltage-Dependent, Open Channel N-Methyl-d-Aspartate Receptor Blocker. In: Molnar, P., Hickman, J.J. (eds) Patch-Clamp Methods and Protocols. Methods in Molecular Biology™, vol 403. Humana Press. https://doi.org/10.1007/978-1-59745-529-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-59745-529-9_2
Publisher Name: Humana Press
Print ISBN: 978-1-58829-698-6
Online ISBN: 978-1-59745-529-9
eBook Packages: Springer Protocols